Cash Flow Statement

Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Free Cash Flow Gains from Investment Securities Net Cash Flow Net Income Non-cash Items Other financing activities Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Crinetics Pharmaceuticals (CRNX) Amortization of Deferred Charges (2019)

Crinetics Pharmaceuticals (CRNX) has 1 years of Amortization of Deferred Charges data on record, last reported at $53000.0 in Q1 2019.